FIELD: medicine; pharmaceutics.
SUBSTANCE: invention discloses intranasal pharmaceutical powder compositions, methods for preparing such compositions and use thereof. Powder composition includes spray-dried particles which include an active agent, a carrier, a thickener, which is hydroxypropyl methylcellulose, and sugar alcohol, which is mannitol, where the carrier includes microcrystalline cellulose and an active agent, spray-dried together with microcrystalline cellulose to produce spray-dried particles.
EFFECT: implementation of the purpose is provided.
66 cl, 12 tbl, 7 ex, 8 dwg
Title | Year | Author | Number |
---|---|---|---|
DRY PHARMACEUTICAL COMPOSITIONS CONTAINING NANOPARTICLES OF ACTIVE AGENT BOUND TO CARRIER PARTICLES | 2014 |
|
RU2715714C2 |
LENALIDOMIDE TABLET COMPOSITION FOR ORAL ADMINISTRATION | 2017 |
|
RU2725074C1 |
COMPOSITIONS, DEVICES AND METHODS FOR THE TREATMENT OF ALCOHOL DEPENDENCE | 2017 |
|
RU2767062C2 |
METHODOLOGY PREPARATIONS | 2014 |
|
RU2684914C2 |
COMPOSED TRAMADOLE OF PROLONGED RELEASE WITH 24- HOUR ACTION | 2003 |
|
RU2328275C2 |
PHARMACEUTICAL COMPOSITIONS OF COCRYSTALS OF TRAMADOL AND COXIBS | 2011 |
|
RU2567843C2 |
INTRANASAL DEXMEDETOMIDINE COMPOSITIONS AND METHODS OF USE THEREOF | 2012 |
|
RU2692245C2 |
PHARMACEUTICAL DOSAGE FORMS AND COMPOSITIONS OF COLON ABSORBED PHENYLEPHRINE | 2007 |
|
RU2454225C2 |
PREPARING DOSAGE FORMS OF CONTROLLED-RELEASE SKELETAL MUSCLE RELAXANT | 2009 |
|
RU2540494C2 |
TABLETS OF ULIPRISTAL ACETATE | 2009 |
|
RU2492853C2 |
Authors
Dates
2024-04-24—Published
2017-08-04—Filed